| Q46842310 | A novel BAP1 mutation is associated with melanocytic neoplasms and thyroid cancer. |
| Q42465699 | A recurrent germline BAP1 mutation and extension of the BAP1 tumor predisposition spectrum to include basal cell carcinoma |
| Q30382522 | Analysis of BAP1 Germline Gene Mutation in Young Uveal Melanoma Patients |
| Q28397624 | BAP1 hereditary cancer predisposition syndrome: a case report and review of literature |
| Q33890512 | BAP1, a tumor suppressor gene driving malignant mesothelioma |
| Q59808380 | Comparison of Germline versus Somatic BAP1 Mutations for Risk of Metastasis in Uveal Melanoma |
| Q90281138 | Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide |
| Q28397229 | Comprehensive review of BAP1 tumor predisposition syndrome with report of two new cases |
| Q55665416 | Detecting germline BAP1 mutations in patients with peritoneal mesothelioma: benefits to patient and family members. |
| Q64082606 | Exploring the hereditary background of renal cancer in Denmark |
| Q92423194 | Families with BAP1-Tumor Predisposition Syndrome in The Netherlands: Path to Identification and a Proposal for Genetic Screening Guidelines |
| Q89659606 | Genetic Predisposition to Breast and Ovarian Cancers: How Many and Which Genes to Test? |
| Q47858202 | Genetic prognostication in uveal melanoma |
| Q34449957 | Genetics of familial melanoma: 20 years after CDKN2A. |
| Q53390123 | Genomic spectra of biliary tract cancer. |
| Q47972869 | Genotypic and Phenotypic Features of BAP1 Cancer Syndrome: A Report of 8 New Families and Review of Cases in the Literature. |
| Q38805682 | Germline BAP1 alterations in familial uveal melanoma. |
| Q37171825 | Germline BAP1 mutations misreported as somatic based on tumor-only testing |
| Q89506007 | Germline alterations in patients with biliary tract cancers: A spectrum of significant and previously underappreciated findings |
| Q92446122 | Germline large deletion of BAP1 and decreased expression in non-tumor choroid in uveal melanoma patients with high risk for inherited cancer |
| Q34194566 | Germline mutation of Bap1 accelerates development of asbestos-induced malignant mesothelioma |
| Q36599690 | Hereditary melanoma: Update on syndromes and management: Emerging melanoma cancer complexes and genetic counseling |
| Q40852568 | Hereditary renal tumors: More common than expected? |
| Q53533612 | Histomorphologic spectrum of BAP1 negative melanocytic neoplasms in a family with BAP1-associated cancer susceptibility syndrome. |
| Q90612169 | How asbestos and other fibers cause mesothelioma |
| Q45361587 | Inference on germline BAP1 mutations and asbestos exposure from the analysis of familial and sporadic mesothelioma in a high-risk area |
| Q28384496 | Loss of BAP1 Expression Occurs Frequently in Intrahepatic Cholangiocarcinoma |
| Q58612052 | Loss of BAP1 expression is associated with genetic mutation and can predict outcomes in gallbladder cancer |
| Q28387556 | Loss of expression of BAP1 is a useful adjunct, which strongly supports the diagnosis of mesothelioma in effusion cytology |
| Q47614777 | Malignant Peripheral Nerve Sheath Tumor in a Patient With BAP1 Tumor Predisposition Syndrome |
| Q34044830 | Melanoma genetics |
| Q90612188 | Mesothelioma developing in carriers of inherited genetic mutations |
| Q34917972 | Mesothelioma patients with germline BAP1 mutations have 7-fold improved long-term survival. |
| Q89366198 | Molecular analysis of an asbestos-exposed Belgian family with a high prevalence of mesothelioma |
| Q56428911 | Molecular pathology of cutaneous melanoma |
| Q57785337 | Multiple tumor suppressors regulate a HIF-dependent negative feedback loop via ISGF3 in human clear cell renal cancer |
| Q50222046 | Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing. |
| Q35638401 | Nephron-sparing surgery for multifocal and hereditary renal tumors |
| Q49698247 | Patterns of BAP1 protein expression provide insights into prognostic significance and the biology of uveal melanoma |
| Q58553501 | Sensitivity to asbestos is increased in patients with mesothelioma and pathogenic germline variants in BAP1 or other DNA repair genes |
| Q41162225 | Somatic BRCA1-associated protein 1 (BAP1) loss is an early and rare event in esophageal adenocarcinoma |
| Q36092850 | Somatic alteration and depleted nuclear expression of BAP1 in human esophageal squamous cell carcinoma |
| Q57646732 | Staging Uveal Melanoma with Whole-Body Positron-Emission Tomography/Computed Tomography and Abdominal Ultrasound: Low Incidence of Metastatic Disease, High Incidence of Second Primary Cancers |
| Q38214084 | The Importance of Multidisciplinary Approach in Early Detection of BAP1 Tumor Predisposition Syndrome: Clinical Management and Risk Assessment |
| Q28083152 | The roles of chromatin-remodelers and epigenetic modifiers in kidney cancer |
| Q26778756 | Update in genetic susceptibility in melanoma |